← Back to Search

Artificial Intelligence

AI Genetic Counseling vs In-Person Genetic Counseling for Breast Cancer

N/A

Recruiting

Led By Zahraa Al-Hilli, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects diagnosed with Stage 0-3 breast cancer

Patients who do not satisfy current NCCN criteria for referral to a genetics counselor and genetics testing

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial is studying the feasibility of using AI to help with genetic counseling for women with breast cancer.

Who is the study for?

This trial is for women recently diagnosed with Stage 0-3 breast cancer who don't meet the criteria for genetic testing as per NCCN guidelines. Participants must understand and be willing to sign a consent form and complete study questionnaires.Check my eligibility

What is being tested?

The study compares traditional in-person genetic counseling with an AI-powered ChatBot program for patients. It aims to see if AI can help manage the increased demand for genetic counseling due to offering testing to all regardless of NCCN criteria.See study design

What are the potential side effects?

Since this trial involves surveys, counseling, and genetic testing rather than medication or invasive procedures, there are no direct physical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My breast cancer is at stage 0 to 3.

Select...

I do not meet the criteria for genetic counseling according to NCCN guidelines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Genetic screening method

Overall comprehension as assessed by BCGCKQ

Percent of participants who took up genetic testing after not meeting NCCN guidelines for genetic testing

Secondary outcome measures

Frequencies of most common reasons for not pursuing genetic testing

Number of patients who decline genetic testing

Percentage of overall cohort with mutation

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Artificial intelligence programExperimental Treatment4 Interventions

Will complete consult with the use of an artificial intelligence program Chatbot.

Group II: in-person genetic counselingActive Control4 Interventions

Will complete a traditional in-person genetic counseling. consult by meeting with a Genetics Counselor

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Genetic testing

2017

N/A

~5890

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

452 Previous Clinical Trials

31,810 Total Patients Enrolled

54 Trials studying Breast Cancer

4,867 Patients Enrolled for Breast Cancer

Zahraa Al-Hilli, MDPrincipal InvestigatorCleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

1 Previous Clinical Trials

100 Total Patients Enrolled

1 Trials studying Breast Cancer

100 Patients Enrolled for Breast Cancer

Media Library

Automated program (ChatBot) (Artificial Intelligence) Clinical Trial Eligibility Overview. Trial Name: NCT04354675 — N/A

Breast Cancer Research Study Groups: Artificial intelligence program, in-person genetic counseling

Breast Cancer Clinical Trial 2023: Automated program (ChatBot) Highlights & Side Effects. Trial Name: NCT04354675 — N/A

Automated program (ChatBot) (Artificial Intelligence) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04354675 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is admission to this clinical trial available for individuals at this time?

"Affirmative. The information present on clinicaltrials.gov reveals that this investigation is actively searching for study participants to join its ranks. This endeavor was initially published on June 29th 2021, and the most recent edit took place on November 22nd 2022. A total of 100 individuals are being recruited from a single location."

Answered by AI

What is the scope of individuals taking part in this experiment?

"Affirmative. Data hosted on clinicaltrials.gov evidences that this medical trial, which was published on June 29th 2021, is currently recruiting individuals. Approximately 100 participants need to be enrolled from 1 different research centre."

Answered by AI

What are the ultimate goals of this particular experiment?

"This two-year trial is aiming to measure the percentage of participants who opted for genetic testing despite not meeting the NCCN criteria. It will also investigate how often people decline this type of testing and compare mutation rates between different groups using Chi-square or Fisher's exact tests."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

2021. "Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04354675.